Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Novell survey shows UK employees could be a virus infection risk
- CORPORATE IT UPDATE-C1995-2004 M2 COMMUNICATIONS LTD
- Research articles 2004-02-06
- Websense EIM Software Protects Corporations Against Web-Based ``Nimda'' Virus Infection
- Business Editors/High-Tech Writers
- Research articles 2001-10-01
- McAfee Unveils Anti-Virus Breakthrough; Bootshield First Anti-Virus Software to Prevent Boot Virus Infections; Ordinary Anti-Virus Software Unable to Prevent Boot Viruses Which Account for Over 70% of all Virus Infections
- SANTA CLARA, Calif.--BUSINESS WIRE--Dec. 19, 1995--McAfee (Nasdaq: MCAF) today unveiled BootShield, an anti-virus software package capable of preventing boot virus infections. The software represents a true breakthrough in the struggle against boot virus infections, which cause immeasurable data loss each year for thousands of computer users. Until now,...
- Research articles 1995-12-19
- Gilead Sciences Announces Results From Phase III Study of Adefovir Dipivoxil in Precore Mutant Chronic Hepatitis B Virus Infection
- Business Editors and Health/Medical Writers
- Research articles 2001-09-19
Additional Resources
- US DEPT OF HHS: Hepatitis E virus infection may be wi widespread in rats.
- M2 PRESSWIRE-20 August 1999-US DEPT OF HHS: Hepatitis E virus infection may be widespread in rats C1994-99 M2 COMMUNICATIONS LTD RDATE:180899 A study led by researchers at the National Institutes of Health NIH suggests that hepatitis E virus HEV is common among...
- Research articles 1999-08-20
- Scientists of New York Blood Center Discover Promising Compound to Protect Against SARS Virus Infection
- NEW YORK, March 22 /U.S. Newswire/ -- As recently reported in The Lancet (Vol. 363: 938-947, 2004), scientists from New York Blood Center's Lindsley F. Kimball Research Institute and other research partners, have identified a new peptide that would potentially protect patients from SARS virus infection. "The discovery of this...
- Research articles 2004-03-22
- Alnylam Submits IND Application for ALN-RSV01, an RNAi Therapeutic for the Treatment of Respiratory Syncytial Virus Infection; Represents First RNAi Therapeutic for Viral Infectious Diseases and Alnylam's Lead Clinical-Stage Program
- CAMBRIDGE, Mass. -- Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that it has submitted an investigational new drug IND application to the U.S. Food and Drug Administration FDA to initiate a human clinical trial of ALN-RSV01, its proprietary RNAi therapeutic for the treatment of patients...
- Research articles 2005-11-01
- Flamel Technologies Announces Positive Preliminary Results of a Phase I/II Trial of IFN-alpha-XL in Patients with Chronic Hepatitis C Virus Infection
- LYON, France -- Flamel Technologies (NASDAQ:FLML) today announced positive preliminary Phase I/II data from a trial demonstrating the safety, tolerability, and long-acting activity of IFN-alpha-XL in patients with chronic hepatitis C virus HCV infection. Data also show that IFN-alpha-XL had positive effects on viral load and interferon activity biomarkers. IFN-alpha-XL...
- Research articles 2005-09-23
- Flamel Technologies Announces Positive Top Line Results of a Clinical Trial of IFN-alpha-XL versus PegIntron™ in Patients with Chronic Hepatitis C Virus Infection
- LYON, France -- Flamel Technologies (NASDAQ:FLML) today announced positive preliminary data from a trial comparing the safety, tolerability, and long-acting activity of IFN-alpha-XL versus ViraferonPeg[TM], marketed in the U.S. as PegIntron[TM], in patients with chronic hepatitis C virus HCV infection. Results from the trial show:
- Research articles 2007-10-25
- Genmab's HuMax-HepC Prevents Hepatitis C Virus Infection in Animal Model.
- COPENHAGEN, Denmark, May 21 /PRNewswire/ -- Genmab A/S (CSE: GEN) announced today its fully human antibody HuMax-HepCTM prevented Hepatitis C virus HCV infection in a novel animal model. In the pre-clinical study, mice with a compromised immune system were transplanted with human...
- Research articles 2007-05-21
- Electric Mail Co.'s E-mmunity Service Eliminates Virus Threat of Microsoft and Netscape E-mail Bug
- VANCOUVER, BRITISH COLUMBIA--BUSINESS WIRE--July 31, 1998--The Electric Mail Co(VSE:ELE.) The Electric Mail Company Inc. (VSE:ELE), a leading E-mail Service Provider ESP, announced today that its E-mmunity service protects corporate networks from the potential virus infection associated with the recently discovered "longfilename e-mail bug". The "longfilename e-mail bug", which may allow...
- Research articles 1998-07-31
- Electric Mail Co.'s E-mmunity Service Eliminates Virus Threat of Microsoft and Netscape E-mail Bug
- VANCOUVER, BRITISH COLUMBIA--BUSINESS WIRE--July 31, 1998--The Electric Mail Co(VSE:ELE.) The Electric Mail Company Inc. (VSE:ELE), a leading E-mail Service Provider ESP, announced today that its E-mmunity service protects corporate networks from the potential virus infection associated with the recently discovered "longfilename e-mail bug". The "longfilename e-mail bug", which may allow...
- Research articles 1998-07-31
- Virus discovered deep in Delphi programming language
- A new virus outbreak has been detected and reportedly spreading quickly. Researchers at SonicWALL and SophosLabs claim that the Win32.Induc virus infects applications built using Delphi, an object-oriented, visual programming environment derived from the Pascal language, used to develop applications for deployment on the web, Windows and Linux. Once a computer is infected, any code or documents...
- News items 2009-08-19
- FDA licenses vaccine vs. bird flu infection
- The first U.S. vaccine to prevent human infection with a deadly bird flu virus was licensed Tuesday by the Food and Drug Administration. Made by Sanofi Pasteur under contract with the U.S. Department of Health and Human Services, the vaccine won't be available commercially, but will...
- Research articles 2007-04-18
- Eset's NOD32 Identifies New Version of Sober Worm; NOD32 Users Are Immediately Protected from Infection without Having to Wait for an Updated Signature
- SAN DIEGO -- Eset, a global security software solutions company providing next-generation virus protection, today announced that the company's flagship product, NOD32 antivirus, detected a new variant of the Sober worm family -- Win32/Sober.L. Cases of infection have been reported in Germany and Spain so far, and infection continues to...
- Research articles 2005-03-07
- Outbreak of Nipah-like virus kills 14 in Bangladesh: WHO
- GENEVA AFP ? Fourteen people have died in western Bangladesh from an outbreak of a viral infection which resembles the deadly Nipah virus, the World Health Organisation said. Tests by the US Center for Disease Control have so far confirmed "Nipah-like virus" in nine of the 42 cases which...
- Research articles 2004-02-13
- Roche.(oseltamivir phosphate)
- ROCHE has submitted Tamiflu oseltamivir phosphate to the Japanese Ministry of Health and Welfare for regulatory approval for A and B influenza virus infection in adults, including both treatment and prophylaxis. The medication targets one of two ROCHE has submitted Tamiflu oseltamivir phosphate...
- Research articles 2000-08-07
- TENOFOVIR DISOPROXIL FUMARATE.(Viread from Gilead Sciences approved)(Brief Article)
- TENOFOVIR DISOPROXIL FUMARATE Gilead Sciences received FDA approval for antiretroviral agent Viread tenofovir disoproxil fumarate for human immunodeficiency virus infection when taken in ... TENOFOVIR DISOPROXIL FUMARATE Gilead Sciences received FDA approval for antiretroviral agent Viread tenofovir disoproxil fumarate for human immunodeficiency virus...
- Research articles 2001-11-05
- HHS Bans Rodent Imports from Africa; Prohibits Domestic Commerce in Rodents and Prairie Dogs
- WASHINGTON, June 11 /U.S. Newswire/ -- HHS Secretary Tommy G. Thompson today announced an immediate embargo on the importation of all rodents from Africa due to the potential that these rodents can spread monkeypox virus infection to other animal species WASHINGTON, June 11 /U.S. Newswire/ -- HHS Secretary Tommy G....
- Research articles 2003-06-11
- U.S. HHS: Pool of latently infected, "resting" cells established early in HIV infection
- M2 PRESSWIRE-21 July 1998-U.S. HHS: Pool of latently infected, "resting" cells established early in HIV infection C1994-98 M2 COMMUNICATIONS LTD RDATE:200798 Soon after the human immunodeficiency virus HIV enters a person's body, the virus sets up shop in resting (non-dividing) CD4+ T cells, according...
- Research articles 1998-07-21
- << Previous
- page 1 of 1
- Next >>
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
